ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
7.30
+0.16 (2.24%)
At close: Apr 2, 2026, 4:00 PM EDT
7.24
-0.06 (-0.82%)
After-hours: Apr 2, 2026, 7:59 PM EDT
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $7.54 billion as of April 2, 2026. Its market cap has increased by 220.05% in one year.
Market Cap
7.54B
Enterprise Value
8.14B
1-Year Change
220.05%
Ranking
Category
Stock Price
$7.30
Market Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from $14.82B to $7.54B, a decrease of -49.14%. That is a compound annual growth rate of -12.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 7.54B | 286.56% |
| Dec 31, 2025 | 1.95B | 4.33% |
| Dec 31, 2024 | 1.87B | -44.23% |
| Dec 29, 2023 | 3.35B | 61.49% |
| Dec 30, 2022 | 2.08B | -14.18% |
| Dec 31, 2021 | 2.42B | -83.68% |
| Mar 10, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxcyte | 8.42B |
| Bio-Techne | 8.37B |
| Nuvalent | 8.31B |
| Cytokinetics | 8.20B |
| Halozyme Therapeutics | 7.75B |
| Krystal Biotech | 7.57B |
| Kymera Therapeutics | 6.93B |
| Arcellx | 6.73B |